CVE-2009-1172

Description

The JAX-RPC WS-Security runtime in the Web Services Security component in IBM WebSphere Application Server (WAS) 6.1 before 6.1.0.23 and 7.0 before 7.0.0.3, when APAR PK41002 is installed, does not properly validate UsernameToken objects, which has unknown impact and attack vectors.

Category

10.0
CVSS
Severity: Critical
CVSS 2.0 •
EPSS 1.33% Top 25%
Vendor Advisory ibm.com Vendor Advisory secunia.com Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www-01.ibm.com/support/docview.wss?uid=swg27007951 patch
http://secunia.com/advisories/34131 third party advisory vendor advisory
http://secunia.com/advisories/34461 third party advisory vendor advisory
http://www-01.ibm.com/support/docview.wss?uid=swg1PK75992 vendor advisory
http://www-01.ibm.com/support/docview.wss?uid=swg27014463 patch
http://www-01.ibm.com/support/docview.wss?uid=swg21367223
http://www.securityfocus.com/bid/34502 vdb entry

Frequently Asked Questions

What is the severity of CVE-2009-1172?
CVE-2009-1172 has been scored as a critical severity vulnerability.
How to fix CVE-2009-1172?
To fix CVE-2009-1172, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2009-1172 being actively exploited in the wild?
It is possible that CVE-2009-1172 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.